ACTRN12617001016325撤回4 期
Prospective randomised trial of change of progesterone dosage in HRT FETs with low serum progesterone concentrations after 2 days of progesterone pessary treatment
适应症
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 入组人数
- 304
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 45 Years（—）
- 性别
- Female
入选标准
- •1. Is a female receiving single embryo FET with HRT at Monash IVF
- •2. Is between the age of 18 and 45 years
- •3. Has provided informed consent
- •4. Speaks sufficient English to provide informed consent
- •5. Has been prescribed an initial progesterone pessary dose of 400mg bd or tds and is obtaining these pessaries from Slade pharmacy
- •6. Low serum progesterone levels at Day 2 of progesterone treatment (<50nmol/L)
排除标准
- •Already completed an HRT FET cycle in this study
- •Planned double embryo transfer.
研究者
相似试验
已完成
不适用
ational randomised trial of hormone replacement therapy (HRT) in women with a history of early stage breast cancerBreastCancerISRCTN29941643Individual Sponsor (UK)3,000
进行中（未招募）
1 期
A study to learn how diffent drugs used in the treatment of HIV may influence brain function in patients who are HIV positive and who have not had any previous treatment for this condition.HIV infection and cognitive functionEUCTR2011-002656-14-GBImperial College60
进行中（未招募）
1 期
A randomised prospective study assessing changes in neuro-cognitive function, using a computerised test battery, in treatment naïve HIV-1 positive subjects commencing two different antiretroviral regimens. - CogNaive StudyHIVEUCTR2007-002405-47-GBImperial College20
已完成
不适用
The PROOF trial: PROtecting Ovaries and Fertility during chemotherapyISRCTN96797814Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute30
已完成
不适用
Prospective randomized trial to evaluate the prognostic role of lymphnode dissection in men with prostate cancer treated with radical prostatectomyC61Malignant neoplasm of prostateDRKS00019941Martini-Klinik am UKE GmbH1,805